EP4531816
PHARMACEUTICAL FORMULATIONS OF BICTEGRAVIR AND LENACAPAVIR
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
14.8.2024EP published:
31.12.2025EP application number:
24755477.7
EPO information:
European Patent Register
Max expiry date:
13.8.2044Expiry date:
13.8.2026
Title in English:
PHARMACEUTICAL FORMULATIONS OF BICTEGRAVIR AND LENACAPAVIRLanguage of the patent:
English
Timeline
Today
14.8.2024EP application
31.12.2025EP Publication
13.8.2026Expires
Owner
Name:
Gilead Sciences, Inc.Address:
333 Lakeside Drive, Foster City, CA 94404, US
Inventor
Name:
ARORA, PriyankaAddress:
Foster City, California 94404, US
Name:
CLAMPFFER, Marina A.Address:
Foster City, California 94404, US
Name:
FOGARTY, Julie A.Address:
Foster City, California 94404, US
Priority
Number:
202363519675 PDate:
15.8.2023Country:
US
Number:
23201068Date:
29.9.2023Country:
EP
Classification
Categories:
A61K 9/24, A61K 9/20, A61K 31/4439, A61K 31/553, A61K 31/13, A61P 31/18